Press-release for stocks in the professional, scientific, and technical services sector

Prices are updated after-hours

sector : Professional, scientific, and technical services crawled time : 13:30

save search

Gain Therapeutics Bolsters Management Team with the Appointment of Gene Mack as Chief Financial Officer
Published: 2024-04-08 (Crawled : 13:30) - globenewswire.com
GANX | $3.155 0.16% 0.16% 71K

Professional, Scientific, and T...

| -10.67% | O: 0.28% H: 0.0% C: -3.92%
management therapeutics financial

Aerovate Therapeutics to Present Patient Baseline Characteristics of the Phase 2b Portion of the Phase 2b/Phase 3 IMPAHCT Trial at the American Thoracic Society 2024 International Conference
Published: 2024-03-27 (Crawled : 13:30) - globenewswire.com
AVTE M | $21.86 1.2% 1.19% 220K

Professional, Scientific, and T...

| -14.04% | O: 6.78% H: 7.19% C: 4.05%
conference international trial therapeutics

RENNOVA HEALTH, INC., ANNOUNCES THE EXPIRATION OF WARRANTS TO PURCHARE OVER FOUR HUNDRED BILLION COMMON SHARES
Published: 2024-03-26 (Crawled : 13:30) - globenewswire.com
RNVA | $0.0001 0.0% 140M

Professional, Scientific, and T...

| Email alert Add to watchlist

Molecular Partners Publishes Invitation to Annual General Meeting 2024
Published: 2024-03-26 (Crawled : 13:30) - globenewswire.com
MOLN | News | $3.74 -3.54% 6.2K

Professional, Scientific, and T...

| -20.57% | O: -5.14% H: 6.94% C: 6.94%
meeting molecular

VML and Definitive Healthcare announce partnership to transform key opinion leader management
Published: 2024-03-22 (Crawled : 13:30) - globenewswire.com
DH | $7.06 0.28% 0.28% 530K

Professional, Scientific, and T...

| -10.75% | O: -1.14% H: 0.51% C: -2.69%
WPP | $48.18 0.15% 0.0% 440K

Commercial Services

| 4.69% | O: 1.74% H: 0.75% C: -0.47%
partnership management key

Dominari Securities LLC Continues to Add Depth with Three New Hires
Published: 2024-03-07 (Crawled : 13:30) - prnewswire.com
DOMH | $2.82 0.71% 0.71% 12K

Professional, Scientific, and T...

| 31.07% | O: -2.18% H: 6.33% C: 5.21%

Werewolf Therapeutics to Present at the 2024 Leerink Partners Global Biopharma Conference
Published: 2024-03-06 (Crawled : 13:30) - werewolftx.com
HOWL | $5.91 0.68% 0.68% 120K

Professional, Scientific, and T...

| -13.62% | O: 2.05% H: 2.87% C: 0.86%
conference biopharma global therapeutics

IPA to Report Financial Results and Recent Business Highlights for Third Quarter Fiscal Year 2024 on March 14, 2024
Published: 2024-03-04 (Crawled : 13:30) - biospace.com/
IPA | $1.24 0.0% 150K

Professional, Scientific, and T...

| -32.98% | O: -1.06% H: 0.0% C: -4.84%
report business year financial results

Breaking Ground in Prostate Cancer: BriaCell Announces Lead Prostate Cancer Candidate Bria-Pros+, Initiates GMP Manufacturing
Published: 2024-02-06 (Crawled : 13:30) - globenewswire.com
BCTX | $2.19 -5.6% -5.94% 140K

Professional, Scientific, and T...

| -29.77% | O: 9.41% H: 1.16% C: -3.72%
candidate cancer

OMNIQ ANNOUNCES THE ACQUISITION OF CODEBLOCKS LTD A LEADING FINTECH SOFTWARE DEVELOPER
Published: 2024-02-05 (Crawled : 13:30) - globenewswire.com
OMQS | $0.4533 -15.65% -18.55% 340K

Professional, Scientific, and T...

| -17.0% | O: 6.75% H: 0.0% C: -0.07%
software acquisition

TransCode Therapeutics and Debiopharm Announce Collaboration to Develop Targeted Nucleic Acid Therapeutics for Cancer
Published: 2024-01-29 (Crawled : 13:30) - globenewswire.com
RNAZ | $0.49 -2.39% -2.45% 110K

Professional, Scientific, and T...

| -36.83% | O: 14.42% H: 1.21% C: -10.29%
cancer collaboration therapeutics

OMNIQ RECEIVES $5.0M IN PURCHASE ORDERS FOR THE SUPPLY OF HARDWARE, SOFTWARE AND SERVICES FOR ONE OF THE LARGEST US BASED FOOD AND DRUG CHAINS.
Published: 2024-01-24 (Crawled : 13:30) - globenewswire.com
OMQS | $0.4533 -15.65% -18.55% 340K

Professional, Scientific, and T...

| -27.86% | O: 4.92% H: 0.0% C: -9.77%
drug services food software one

BriaCell Reports Unprecedented Preliminary Survival and Clinical Benefit in Antibody-Drug Conjugate (ADC) Refractory Patient Subset
Published: 2023-12-20 (Crawled : 13:30) - globenewswire.com
BCTX | $2.19 -5.6% -5.94% 140K

Professional, Scientific, and T...

| -29.95% | O: 1.02% H: 11.56% C: 2.51%

Quoin Pharmaceuticals Announces FDA Clearance of Clinical Optimization Plan for QRX003 for Netherton Syndrome
Published: 2023-12-13 (Crawled : 13:30) - globenewswire.com
QNRX | $0.6988 -2.94% -3.03% 41K

Professional, Scientific, and T...

| -84.73% | O: 5.38% H: 4.77% C: -6.33%
qrx003 fda clearance pharmaceuticals

TransCode Therapeutics Reports Positive Pre-Clinical Results in Metastatic Pancreatic Cancer with its Lead Candidate, TTX-MC138
Published: 2023-12-12 (Crawled : 13:30) - globenewswire.com
RNAZ | $0.49 -2.39% -2.45% 110K

Professional, Scientific, and T...

| -93.6% | O: 11.94% H: 0.0% C: -19.05%
mc138 ttx-mc138 pre-clinical positive cancer pancreatic therapeutics results

Biomea Fusion Announces Health Canada Clearance of Clinical Trial Application (CTA) for BMF-219 in Type 1 Diabetes
Published: 2023-12-05 (Crawled : 13:30) - globenewswire.com
BMEA | $10.87 -2.6% -2.67% 1.3M

Professional, Scientific, and T...

| -45.2% | O: 5.76% H: 3.01% C: -9.69%
bmf-219 health clearance canada application trial diabetes

Sunshine Biopharma Moves Principal Office to New York City
Published: 2023-12-04 (Crawled : 13:30) - globenewswire.com
SBFM | News | $1.765 -46.84% -88.1% 11M

Professional, Scientific, and T...